These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 33249273)

  • 1. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
    Jurisic A; Jurisic Z; Lefkou E; Girardi G
    Vascul Pharmacol; 2021 Apr; 137():106824. PubMed ID: 33249273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect.
    Jurisic A; Jurisic Z; Lefkou E; Pombo J; Girardi G
    Vascul Pharmacol; 2018 Nov; 110():64-70. PubMed ID: 29879462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.
    Harrington K; Kurdi W; Aquilina J; England P; Campbell S
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):13-8. PubMed ID: 10776007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.
    MacDonald TM; Hui L; Robinson AJ; Dane KM; Middleton AL; Tong S; Walker SP
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):367-375. PubMed ID: 30338593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: comparison and correlation between different Doppler parameters.
    Zimmermann P; Eiriö V; Koskinen J; Kujansuu E; Ranta T
    Ultrasound Obstet Gynecol; 1997 May; 9(5):330-8. PubMed ID: 9201877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Effect of Pravastatin in Early-Onset Fetal Growth Restriction: A Nonrandomized and Historically Controlled Pilot Study.
    Mendoza M; Ferrer-Oliveras R; Bonacina E; Garcia-Manau P; Rodo C; Carreras E; Alijotas-Reig J
    Am J Perinatol; 2021 Dec; 38(14):1472-1479. PubMed ID: 32615618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up.
    Fruci S; Salvi S; Moresi S; Gallini F; Dell'Aquila M; Arena V; Di Stasio E; Ferrazzani S; De Carolis S; Lanzone A
    Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():37-42. PubMed ID: 36764034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction.
    Melchiorre K; Leslie K; Prefumo F; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2009 May; 33(5):524-9. PubMed ID: 19382287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-novo abnormal uteroplacental circulation in third trimester: pregnancy outcome and pathological implications.
    Binder J; Monaghan C; Thilaganathan B; Carta S; Khalil A
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):60-65. PubMed ID: 28640514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.
    García B; Llurba E; Valle L; Gómez-Roig MD; Juan M; Pérez-Matos C; Fernández M; García-Hernández JA; Alijotas-Reig J; Higueras MT; Calero I; Goya M; Pérez-Hoyos S; Carreras E; Cabero L
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):680-9. PubMed ID: 26823208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    Coleman MA; McCowan LM; North RA
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
    Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
    Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between decidual vasculopathy and abnormal uterine artery Doppler measurement.
    Stevens D; Schiffer V; Severens-Rijvers C; de Nobrega Teixeira J; van Haren A; Spaanderman M; Al-Nasiry S
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):910-916. PubMed ID: 35684972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population.
    Gómez O; Martínez JM; Figueras F; Del Río M; Borobio V; Puerto B; Coll O; Cararach V; Vanrell JA
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):490-4. PubMed ID: 16184511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.